Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptides K. FuxeL. F. AgnatiT. Hökfelt OriginalPaper Pages: 3 - 37
Neurochemical effects of some ergot derivatives: A basis for their antiparkinson actions R. Markstein OriginalPaper Pages: 39 - 59
The endocrine profile of bromocriptine: Its application in endocrine diseases Ioana Lancranjan OriginalPaper Pages: 61 - 82
Neuropeptides in striato-nigral pathways A. C. CuelloM. Del FiaccoJ. V. Priestley OriginalPaper Pages: 83 - 96
Dopamine receptors in the parkinsonian brain U. K. RinneP. LönnbergV. Koskinen OriginalPaper Pages: 97 - 106
The effects of lisuride and some other dopaminergic agonists on receptor binding in human brain G. P. ReynoldsP. Riederer OriginalPaper Pages: 107 - 111
Transitional states of central serotonin receptors in Parkinson's disease E. KienzlP. RiedererW. Wesemann OriginalPaper Pages: 113 - 122
Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic response A. AgnoliM. BaldassarreA. Rocco OriginalPaper Pages: 123 - 134
Epidemiology of Parkinson's disease—An overview R. J. MarttilaU. K. Rinne OriginalPaper Pages: 135 - 148
Treatment of Parkinson's disease: Problems with a progressing disease U. K. Rinne OriginalPaper Pages: 161 - 174
Recent advances in the treatment of Parkinson's disease: The role of bromocriptine P. A. Le WittD. B. Calne OriginalPaper Pages: 175 - 184